Table 1.
Characteristics of study population.
| Recipients transfused before 1992 | Recipients transfused in or after 1992 | ||
|---|---|---|---|
|
|
|
||
| No. patients, N (% of total) | 276 459 (18.6) | 1 206 463 (81.4) | |
| Female, N (%) | 161 904 (58.6) | 710 460 (58.9) | |
| Country, N (%) | |||
| Sweden | 242 242 (87.6) | 790 642 (65.5) | |
| Denmark | 34 217 (12.4) | 415 821 (34.5) | |
| Median age at first transfusion (IQR) | 61.9 (40.4-73.5) | 71.2 (56.0-80.6) | |
| Median year of first transfusion (IQR) | 1984 (1978-1988) | 2002 (1998-2007) | |
| Median no. transfusions (IQR) | 2 (2-5) | 3 (2-5) | |
| Median duration of follow-up (IQR) | 13.8 (4.3-25.0) | 4.8 (2.0-9.2) | |
| No. patients with <5 years follow-up, N (%) | 75 362 (31.3) | 624 205 (64.2) | |
| No. patients with 5-10 years follow-up, N (%) | 39 791 (19.1) | 321 653 (24.4) | |
| No. patients with 10-20 years follow-up, N (%) | 51 995 (28.1) | 256 436 (11.3) | |
| No. patients with >20 years follow-up, N (%) | 109 311 (21.5) | 4 169 (0.1) | |
| Disease of donor, N (%)* | |||
| All diagnosis | 7 767 (9.4) | 6 606 (2.2) | |
| All diagnosis-No Viral | 6 467 (8.3) | 5 918 (2.0) | |
| Cirrhosis + Liver Failure | 4 074 (5.5) | 2 825 (1.0) | |
| Cirrhosis + Chronic Hepatitis | 3 232 (4.4) | 1 787 (0.6) | |
| Cirrhosis, PHT, HCC | 2 250 (3.3) | 1 391 (0.5) | |
| Cirrhosis | 1 361 (2.0) | 661 (0.2) | |
| Viral Hepatitis | 1 973 (2.1) | 817 (0.2) | |
| Portal Hypertension | 1 049 (1.5) | 810 (0.3) | |
| Liver Cancer | 437 (0.8) | 237 (0.1) | |
| Latency of disease in donor (years), N (%)* | |||
| <5 years from donation | 1 390 (1.0) | 3 427 (0.7) | |
| 5-9 years from donation | 994 (1.3) | 1 655 (0.8) | |
| ≥10 years from donation | 5 383 (7.2) | 1 524 (0.7) | |
*
The sum of the number of exposed patients exceeds the total number of patients as one patient may be exposed to blood from more than one donor with a later liver disease.